Table 3.

Influence of FHDM, physical inactivity, sarcopenia, obesity, and low adiponectin over the risk of insulin resistance (n = 590).

	Model 1	Model 2	Model 3	Model 4
	OR [95% CI]	OR [95% CI]	OR [95% CI]	OR [95% CI]
FHDM	1.74 [1.10–2.88]*	1.74 [1.10–2.94]*	1.72 [1.10–2.92]*	1.80 [1.10–3.08]*
Physical inactivity	1.77 [1.14–2.75]*	1.49 [0.94–2.37]	1.42 [0.89–2.26]	1.45 [0.90–2.34]
Sarcopenia	(⋯)	4.25 [2.67–6.75]***	2.27 [1.25–4.12]**	2.56 [1.21–4.07]**
Obesity	(⋯)	(⋯)	3.25 [1.71–6.19]***	2.92 [1.51–5.66]**
Low adiponectin	(⋯)	(⋯)	(⋯)	2.22 [1.30–3.77]**
Likelihood ratio (Chi2)	11.46**	48.5***	61.6***	69.8***
Hosmer-Lemeshow	<0.001 (0.99)	0.39 (0.99)	0.18 (0.99)	1.21 (0.98)
Correctly classified	83.6%	83.6%	84.2%	84.6%

OR [95% CI]: odd ratio [95% confidence interval]. Statistical significance: ^* P < 0.05; ^** P < 0.01; ^*** P < 0.001. [⋯]: nonobserved. OR [95% CI]: odd ratio [95% confidence interval]. FHDM: family history of type 2 diabetes in at least one first-degree relative. Obesity: BMI z score ≥2 SD; sarcopenia: FFMI ≤25th percentile; physical inactivity: PA score ≤3; low adiponectin: adiponectin ≤7.9 μg/mL.